U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

Orion Oyj

Market Cap: €6.9b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Novartis

Market Cap: CHF 187.7b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

Roche Holding

Market Cap: CHF 204.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Haleon

Market Cap: UK£34.3b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Amgen

Market Cap: US$152.0b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Basilea Pharmaceutica

Market Cap: CHF 501.0m

Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.

Animalcare Group

Market Cap: UK£155.9m

Develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally.

Aytu BioPharma

Market Cap: US$6.3m

A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

Verici Dx

Market Cap: UK£4.5m

Develops prognostic and diagnostic tests for kidney transplant patients.

Ultragenyx Pharmaceutical

Market Cap: US$3.4b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Illumina

Market Cap: US$11.3b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ALK-Abelló

Market Cap: DKK 32.9b

Operates as an allergy solutions company in Europe, North America, and internationally.

Roche Holding

Market Cap: US$204.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Photocure

Market Cap: NOK 1.8b

Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States.

Orion Oyj

Market Cap: €6.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Bionano Genomics

Market Cap: US$12.2m

Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

Nektar Therapeutics

Market Cap: US$112.9m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

MedinCell

Market Cap: €466.5m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Grifols

Market Cap: €5.0b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Roche Holding

Market Cap: CHF 204.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

OSE Immunotherapeutics

Market Cap: €129.1m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Formycon

Market Cap: €405.2m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Gilead Sciences

Market Cap: €130.3b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Danaher

Market Cap: €133.7b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

AbbVie

Market Cap: US$306.0b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Waters

Market Cap: US$19.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Ryvu Therapeutics

Market Cap: zł461.9m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

BioArctic

Market Cap: SEK 14.7b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

Bonesupport Holding

Market Cap: SEK 20.9b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

MedCap

Market Cap: SEK 5.8b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Siegfried Holding

Market Cap: CHF 3.9b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Insmed

Market Cap: US$13.1b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Goodbody Health

Market Cap: UK£80.3k

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Adocia

Market Cap: €145.0m

A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

argenx

Market Cap: €31.9b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Camurus

Market Cap: SEK 33.2b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.